Rocket


Overview
Financials
News + Filings
IR Vault
Key Docs
Charts
Holdings
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Acq. announced
Quarterly results
CC transcript
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Create: Alert

All | News | Filings
Date FiledTypeDescription
05/10/2018 BW Charles River Laboratories Announces First-Quarter 2018 Results from Continuing Operations
04/12/2018 BW Charles River Laboratories Schedules First-Quarter 2018 Earnings Release and Conference Call
02/13/2018 BW Charles River Laboratories Announces Fourth-Quarter and Full-Year 2017 Results from Continuing Operations and Provides 2018 Guidance
01/25/2018 BW Charles River Laboratories Schedules Fourth-Quarter 2017 Earnings and 2018 Guidance Release and Conference Call
11/09/2017 BW Charles River Laboratories Announces Third-Quarter 2017 Results from Continuing Operations
10/12/2017 BW Charles River Laboratories Changes the Date of Its Third-Quarter 2017 Earnings Release and Conference Call
10/11/2017 BW Charles River Laboratories Schedules Third-Quarter 2017 Earnings Release and Conference Call
09/05/2017 BW Charles River Laboratories to Present at September Investor Conferences
08/09/2017 BW Charles River Laboratories Announces Second-Quarter 2017 Results from Continuing Operations
07/13/2017 BW Charles River Laboratories Schedules Second-Quarter 2017 Earnings Release and Conference Call
06/05/2017 BW Charles River Laboratories to Present at Jefferies Global Healthcare Conference
05/10/2017 BW Charles River Laboratories Announces First-Quarter 2017 Results from Continuing Operations
04/12/2017 BW Charles River Laboratories Schedules First-Quarter 2017 Earnings Release and Conference Call
03/06/2017 BW Charles River Laboratories to Present at Raymond James and Barclays Conferences
02/14/2017 BW Charles River Laboratories Announces Fourth-Quarter and Full-Year 2016 Results from Continuing Operations and Provides 2017 Guidance
02/09/2017 BW Charles River Laboratories Changes Time of Fourth-Quarter 2016 Earnings and 2017 Guidance Conference Call
06/06/2011 BW Charles River to Present at June Investor Conferences
05/09/2011 BW Charles River to Present at Bank of America Merrill Lynch Health Care Conference
05/03/2011 BW Charles River Announces First-Quarter 2011 Results from Continuing Operations
03/03/2011 BW Charles River Announces Agreement to Supply Pfizer's Genetically Modified Research Models
02/24/2011 BW Charles River Implements $150 Million Accelerated Stock Repurchase Program
12/14/2010 BW Charles River Discusses Business Outlook with Investors
11/11/2010 BW Charles River Schedules 2011 Guidance Release and Conference Call
11/03/2010 BW Charles River Announces Third-Quarter 2010 Results
10/13/2010 BW Charles River Announces Exclusive License with Transposagen Biopharmaceuticals, Inc.
10/04/2010 BW Charles River Schedules Third-Quarter 2010 Earnings Release and Conference Call
09/13/2010 BW Charles River to Present at Morgan Stanley and UBS Conferences
08/27/2010 BW Charles River Implements $300 Million Accelerated Stock Repurchase Program
08/02/2010 BW Charles River Announces Second-Quarter 2010 Results
07/29/2010 BW Charles River Announces Mutual Termination of Acquisition Agreement with WuXi PharmaTech
07/15/2010 BW Charles River Schedules Second-Quarter 2010 Earnings Release and Conference Call
07/15/2010 BW Proxy Governance Supports Charles River's Proposed Acquisition of WuXi
07/13/2010 BW Charles River and WuXi File Revised Investor Presentation
07/01/2010 BW Charles River Commences Mailing of Proxy Materials in Connection with WuXi PharmaTech Acquisition
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy